Compare ABCL & IBTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABCL | IBTA |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 855.3M |
| IPO Year | 2020 | 2024 |
| Metric | ABCL | IBTA |
|---|---|---|
| Price | $4.16 | $32.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 7 |
| Target Price | $8.40 | ★ $28.50 |
| AVG Volume (30 Days) | ★ 8.1M | 130.5K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.91 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $75,128,000.00 | ★ $342,389,000.00 |
| Revenue This Year | N/A | $2.02 |
| Revenue Next Year | $21.85 | $8.96 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $1.94 | $19.10 |
| 52 Week High | $6.52 | $55.63 |
| Indicator | ABCL | IBTA |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 44.29 |
| Support Level | $3.96 | $21.23 |
| Resistance Level | $4.84 | $35.11 |
| Average True Range (ATR) | 0.40 | 2.08 |
| MACD | -0.08 | -0.85 |
| Stochastic Oscillator | 21.93 | 29.26 |
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
Ibotta Inc operates a digital promotions platform, the Ibotta Performance Network (IPN), which connects consumer packaged goods (CPG) brands with consumers through a network of publishers. It sources digital offers from clients and distributes them via its technology platform, earning revenue when promotions result in consumer transactions. The platform supports offers across grocery and general merchandise categories, including toys, clothing, beauty, electronics, pet, and home products. The majority of its revenues is derived from the fees charged to clients when consumers redeem offers on the IPN by purchasing promoted products.